Inventor · disambiguated record
Anette Graven Sams
Also filed as: SAMS ANETTE G · SAMS ANETTE GRAVEN
15 granted patents·10 pending applications·62 citations·filing 2005–2022
91Inventor score
Top patents by PatentIndex Score
25 records- 0194US7674912B2Pro-drugs of N-thiazol-2-yl-benzamide derivativesLUNDBECK & CO AS H·Filed 2006·Granted Mar 9, 2010·22 cites·23 claims
- 0293US11548849B2Alcohol derivatives as KV7 potassium channel openersH LUNDBECK AS·Filed 2020·Granted Jan 10, 2023·3 cites·9 claims
- 0393US11434199B2Alcohol derivatives as KV7 potassium channel openersH LUNDBECK AS·Filed 2020·Granted Sep 6, 2022·4 cites·12 claims
- 0488US8815914B2Positive allosteric modulators of nicotinic acetylcholine receptorLUNDBECK & CO AS H·Filed 2013·Granted Aug 26, 2014·8 cites·17 claims
- 0586US8765790B2Positive allosteric modulators of nicotinic acetylcholine receptorLUNDBECK & CO AS H·Filed 2013·Granted Jul 1, 2014·6 cites·16 claims
- 0685US10590067B2Alcohol derivatives of carboxamides as Kv7 potassium channel openersH LUNDBECK AS·Filed 2018·Granted Mar 17, 2020·4 cites·27 claims
- 0785US9050327B2Positive allosteric modulators of nicotinic acetylcholine receptorLUNDBECK & CO AS H·Filed 2013·Granted Jun 9, 2015·5 cites·18 claims
- 0881US12258305B2Alcohol derivatives as Kv7 potassium channel openersH LUNDBECK AS·Filed 2022·Granted Mar 25, 2025·0 cites·20 claims
- 0981US8598213B2Positive allosteric modulators of nicotinic acetylcholine receptorESKILDSEN JOERGEN·Filed 2012·Granted Dec 3, 2013·6 cites·12 claims
- 1080US9549919B2Positive allosteric modulators of nicotinic acetylcholine receptorH LUNDBECK AS·Filed 2015·Granted Jan 24, 2017·2 cites·24 claims
- 1173US2024327336A1Alcohol derivatives as kv7 potassium channel openersH LUNDBECK AS·Filed 2022·Application pending·0 cites
- 1266US9023870B2Positive allosteric modulators of nicotinic acetylcholine receptorLUNDBECK & CO AS H·Filed 2014·Granted May 5, 2015·0 cites·21 claims
- 1363US9889122B2Positive allosteric modulators of nicotinic acetylcholine receptorH LUNDBECK AS·Filed 2016·Granted Feb 13, 2018·0 cites·28 claims
- 1463US2018250277A1Positive allosteric modulators of nicotinic acetylcholine receptorH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1560US8440837B22-substituted-ethynylthiazole derivatives and uses of sameHOPPER ALLEN·Filed 2010·Granted May 14, 2013·1 cites·16 claims
- 1657US2009247593A1N-thiazol-2-yl-benzamide derivativesLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 1754US9586961B2Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereofNIELSEN SIMON FELBDÆK·Filed 2011·Granted Mar 7, 2017·1 cites·9 claims
- 1848US2006154974A1N-thiazol-2-yl-benzamide derivativesSAMS ANETTE G·Filed 2005·Application pending·0 cites
- 1947US2022204489A1ARYLSULFONYLTHIOPHENECARBOXAMIDES AND ARYLSULFONYLFURANCARBOXAMIDES AS Kv3 POTASSIUM CHANNEL ACTIVATORSH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 2047US2013231321A12-substituted-ethynylthiazole derivatives and uses of sameLUNDBECK & CO AS H·Filed 2013·Application pending·0 cites
- 2145US12508239B2Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizuresH LUNDBECK AS·Filed 2020·Granted Dec 30, 2025·0 cites·18 claims
- 2245US2022220095A1N-((HETEROARYL)METHYL)-1-TOSYL-1H-PYRAZOLE-3-CARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERSH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 2342US2020131156A1ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORSH LUNDBECK AS·Filed 2019·Application pending·0 cites
- 2442US2015315130A1New positive allosteric modulators of nicotinic acetylcholine receptorLUNDBECK & CO AS H·Filed 2013·Application pending·0 cites
- 2529US2012252853A1Positive allosteric modulators of nicotinic acetylcholine receptorSAMS ANETTE GRAVEN·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →